Whether B1R located at the ER/nuclear envelope can mediate intracrine regulation of oncogenic pathways associated with aberrant growth, invasion and survival processes of glioma cells are subjects of investigation in our laboratory. The gene discussed is BDKRB1; the disease is central nervous system cancer.